Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
24,400
+1,850 (8.20%)
Jun 29, 2026, 3:30 PM KST
Market Cap297.75B -48.5%
Revenue (ttm)845.30B +4.3%
Net Income23.75B -8.8%
EPS1,944.00 -8.9%
Shares Out 12.20M
PE Ratio12.55
Forward PEn/a
Dividend880.00 (3.90%)
Ex-Dividend DateMay 26, 2026
Volume83,906
Open22,150
Previous Close22,550
Day's Range22,150 - 24,550
52-Week Range22,300 - 76,700
Beta0.32
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2025, Huons Global's revenue was 847.45 billion, an increase of 4.18% compared to the previous year's 813.46 billion. Earnings were 28.84 billion, an increase of 11.82%.

Financial Statements